Richard Herrmann

发表

Pharmacokinetic modeling of the transition of propofol from blood plasma to breathing gas

Martin Grossherr, Sebastian Brandt, Hartmut Gehring, 2014, 2014 IEEE International Symposium on Medical Measurements and Applications (MeMeA).

A fractal approach to the dark silicon problem: a comparison of 3D computer architectures - standard slices versus fractal Menger sponge geometry pdf

Richard Herrmann, R. Herrmann, 2014, ArXiv.

Fractional Calculus in Multidimensional Space — 2D-Image Processing

Richard Herrmann, 2014 .

Covariant fractional extension of the modified Laplace-operator used in 3D-shape recovery

Richard Herrmann, 2011, ArXiv.

Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis.

Susan Branford, Richard Herrmann, R. Herrmann, 2003, Blood.

Phase II, Open-Label Study Evaluating the Activity of Imatinib in Treating Life-Threatening Malignancies Known to Be Associated with Imatinib-Sensitive Tyrosine Kinases

Heikki Joensuu, Richard Herrmann, J. Fletcher, 2008, Clinical Cancer Research.

Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study Group.

Dirk Hasenclever, Peter Koch, Markus Sieber, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

IGF-I induced genes in stromal fibroblasts predict the clinical outcome of breast and lung cancer patients

Richard Herrmann, Michal Rajski, Rosanna Zanetti-Dällenbach, 2010, BMC medicine.

Quantitative determination of JAK2 V617F by TaqMan: An absolute measure of averaged copies per cell that may be associated with the different types of myeloproliferative disorders.

Ian James, Richard Herrmann, Kathryn Shaw, 2007, The Journal of molecular diagnostics : JMD.

Survival in overweight patients with advanced pancreatic carcinoma: a multicentre cohort study

Richard Herrmann, Benjamin Kasenda, R. Herrmann, 2014, BMC Cancer.

Targeting Tumor-Associated Endothelial Cells: Anti-VEGFR2 Immunoliposomes Mediate Tumor Vessel Disruption and Inhibit Tumor Growth

Andreas Wicki, Gerhard Christofori, Richard Herrmann, 2011, Clinical Cancer Research.

Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study.

Andreas Wicki, Richard Herrmann, Lukas Bubendorf, 2012, The Lancet. Oncology.